Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05281237

Avecure Flexible Microwave Ablation Probe For Lung Nodules

Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodule

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)

Detailed description

This will be a single arm, prospective cohort study. The names of the study intervention involved in this study is: * Cone Beam Computed Tomography (CBCT)-guided electromagnetic navigational bronchoscopy (ENB) microwave ablation (MWA) * A rapid on-site evaluation (ROSE) will be performed before the MWA to confirm that the lesion is malignant, this can lead to longer procedure time and time under anesthesia. The research study procedures include screening for eligibility and study treatment including evaluations and follow up visits. * Participants will receive the study intervention and will be followed for 30 days. * It is expected that about 10 people will take part in this research study. This research study is a Pilot Study, which is the first-time investigators are examining this intervention using a bronchoscopic approach for microwave ablation of solitary pulmonary nodules. The U.S. Food and Drug Administration (FDA) has approved this intervention as a treatment option for this disease.

Conditions

Interventions

TypeNameDescription
DEVICEAveCure 16 Gauge Flexible Microwave Ablation ProbeMicrowave ablation of the solitary pulmonary nodule will be performed through a bronchoscopic approach using the AveCure Flexible Microwave Ablation Probe before surgery

Timeline

Start date
2022-06-01
Primary completion
2026-12-30
Completion
2027-06-30
First posted
2022-03-16
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05281237. Inclusion in this directory is not an endorsement.